Consonance Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Consonance Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-305,235	Closed	-$9.87M	–	30
2018 Q2	$9.87M	Sell	305,235 -140,865	-32%	-$3.88M	0.64%	27
2018 Q1	$9.78M	Buy	+446,100	New	+$10.7M	0.89%	22
2015 Q4	–	Sell	-2,326,748	Closed	-$36.9M	–	27
2015 Q3	$36.9M	Sell	2,326,748 -149,539	-6%	-$3.77M	5.19%	9
2015 Q2	$65.5M	Buy	2,476,287 +283,787	+13%	+$9.17M	6.58%	8
2015 Q1	$85.6M	Buy	2,192,500 +57,300	+3%	+$1.97M	7.79%	4
2014 Q4	$64.2M	Buy	2,135,200 +192,146	+10%	+$5.49M	8.27%	3
2014 Q3	$45.9M	Buy	1,943,054 +317,934	+20%	+$9.04M	6.3%	4
2014 Q2	$50.6M	Buy	+1,625,120	New	+$46.9M	7.53%	4
2014 Q1	–	Sell	-1,093,234	Closed	-$37.5M	–	29
2013 Q4	$37.5M	Buy	1,093,234 +214,980	+24%	+$6.25M	6.15%	5
2013 Q3	$17.6M	Buy	878,254 +255,353	+41%	+$5.32M	4.4%	11
2013 Q2	$13.2M	Buy	+622,901	New	+$12.1M	4.7%	11

Other funds holding CSII

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Consonance Capital Management's CSII Position: Q3 2018 in Review

Consonance Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2018, closing a stake of 305,235 shares — an estimated $9.87M sold.

Consonance Capital Management first reported a position in CSII in Q2 2013 and held it in 11 quarters. The position peaked at $85.6M in Q1 2015. 159 funds tracked by Wall St. Rank hold CSII as of Q3 2018.

Consonance Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q3 2018 after selling out during the quarter.
Consonance Capital Management sold 305,235 Cardiovascular Systems, Inc. shares in Q3 2018, an estimated $9.87M.
Consonance Capital Management first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 11 quarters.
Consonance Capital Management's Cardiovascular Systems, Inc. position peaked at $85.6M in Q1 2015.
159 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2018.

Based on Consonance Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.